{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:35:24Z","timestamp":1761824124927,"version":"3.40.5"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.wneu.2019.06.226","type":"journal-article","created":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T11:43:30Z","timestamp":1562586210000},"page":"138-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"130","author":[{"given":"Shizuka","family":"Miyaza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0307-3657","authenticated-orcid":false,"given":"Ryosuke","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsutoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1957-2124","authenticated-orcid":false,"given":"Yasushi","family":"Motoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2019.06.226_bib1","doi-asserted-by":"crossref","first-page":"10018","DOI":"10.1002\/jcp.27860","article-title":"Strategies toward rheumatoid arthritis therapy; the old and the new","volume":"234","author":"Abbasi","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.wneu.2019.06.226_bib2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.wneu.2019.06.226_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2017.1352477","article-title":"Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective","volume":"28","author":"Harigai","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.wneu.2019.06.226_bib4","first-page":"322","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida","year":"2007","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.wneu.2019.06.226_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-008-9069-8","article-title":"Spontaneous remission of \u201cmethotrexate-associated lymphoproliferative disorders\u201d after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature","volume":"26","author":"Rizzi","year":"2009","journal-title":"Med Oncol"},{"key":"10.1016\/j.wneu.2019.06.226_bib6","first-page":"16","article-title":"Methotrexate in rheumatoid arthritis: a quarter century of development","volume":"124","author":"Weinblatt","year":"2013","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.wneu.2019.06.226_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14397595.2018.1472358","article-title":"Japan College of Rheumatology guideline for the use of methotrexate in patients with rheumatoid arthritis","volume":"29","author":"Kameda","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.wneu.2019.06.226_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-015-1040-0","article-title":"Primary central nervous system lymphoma in a rheumatoid arthritis patient treated with methotrexate: a case report","volume":"8","author":"Shimada","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.wneu.2019.06.226_bib9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3109\/s10165-012-0717-7","article-title":"Epstein-Barr virus and methotrexate-related CNS lymphoma in a patient with rheumatoid arthritis","volume":"23","author":"Migita","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.wneu.2019.06.226_bib10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/NEN.0b013e31818beaea","article-title":"Epstein-Barr virus\u2212associated primary CNS lymphomas in elderly patients on immunosuppressive medications","volume":"67","author":"Kleinschmidt-DeMasters","year":"2008","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2019.06.226_bib11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/bjh.14978","article-title":"Methotrexate-associated lymphoproliferative disorder masquerading as multiple cerebral metastases","volume":"180","author":"Matsuda","year":"2018","journal-title":"Br J Haematol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019318844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019318844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T04:13:57Z","timestamp":1569816837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019318844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":11,"alternative-id":["S1878875019318844"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.06.226","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.06.226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}